Table 8 Table a2

From: Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer

Study Chair R Basser
Scientific Committee A Goldhirsch, AS Coates (Co-Chairs)
Foundation Council B Thürlimann (President), M Castiglione-Gertsch, AS Coates, JP Collins, H Cortés Funes, RD Gelber, A Goldhirsch, M Green, A Hiltbrunner, SB Holmberg, DK Hossfeld, P Karlsson, I Láng, J Lindtner, M de Stoppani, C-M Rudenstam, R Stahel, H-J Senn, A Veronesi
Coordinating Center (Bern, Switzerland) M Castiglione-Gertsch (CEO), A Hiltbrunner (Director), G Egli, M Rabaglio, R Studer, B Ruepp, M Schärlig-Strausak, R Maibach
Statistical Center (Harvard School of Public Health and Dana-Farber Cancer Institute, Boston, MA, USA) RD Gelber (Group Statistician), K Price (Director of Scientific Administration), A O’Neill (Study Statistician), S Gelber, D Zahrieh, M Bonetti, A Keshaviah, M Regan
Quality of Life Office (Bern, Switzerland) J Bernhard, Ch. Hürny, H Gusset, G Egli
Pathology Office B Gusterson, G Viale, V Spataro
Data Management Center (Frontier Science & Tech. Res. Found., Amherst, NY, USA): L Blacher (Director), J Celano, M Isley, R Hinkle, S Lippert, K Scott
Australian New Zealand Breast Cancer Trials Group (ANZ BCTG) JF Forbes, AS Coates, A Wilson, D Lindsay, D Preece
-Statistical Center, NHMRC CTC, University of Sydney RJ Simes, V Gebski, H Dhillon
-The Cancer Council Victoria, Melbourne, VIC J Collins, R Snyder, E Abdi, R Basser, WI Burns, M Chipman, J Chirgwin, V Ganju, M Green, S McLachlan, D Howell, M Prince, A Schwarer, G Toner, C Underhill
-Canberra Hospital, Canberra, ACT P Craft, S Harris, R Pembrey
-Newcastle Mater Misericordiae Hospital, Waratah, Newcastle, NSW JF Forbes, J Stewart, S Ackland, A Bonaventura
-Mater Adult Hospital, Brisbane, QLD K Taylor
-Prince of Wales Hospital, Randwick, NSW M Friedlander, B Brigham, C Lewis, D Goldstein
-Queen Elizabeth Hospital, Woodville, SA D Kotasek
-Royal Adelaide Hospital, Adelaide, SA, IN Olver, PG Gill, D Keefe
-Royal Brisbane Hospital, Brisbane, QLD R Abraham, D Wyld
-Royal North Shore Hospital, St Leonards, NSW F Boyle, S Durrant, D Bell
-Royal Prince Alfred Hospital, Sydney J Beith, M Boyer, AS Coates, A Sullivan
-Sir Charles Gairdner Hospital, Nedlands, WA M Byrne, G van Hazel, J Dewar
-Auckland Hospital, Auckland, New Zealand VJ Harvey, P Thompson, D Porter, M McCrystal
Istituto Europeo di Oncologia, Milano, Italy G Martinelli, F Peccatori, U Veronesi, G Viale, A Luini, R Orecchia, S Cinieri, E Cocorocchio, G Renne, G Mazzarol, M Colleoni, A Agazzi, F Nolè, A Costa, S Zurrida, P Veronesi, V Sacchini, V Galimberti, F de Braud, G Peruzzotti, F Didier, A Goldhirsch
Ospedale Infermi, Rimini, Italy A Ravaioli, D Tassinari, G Oliverio, F Barbanti, P Rinaldi, L Gianni, G Drudi
The Chinese University of Hong Kong N Wickham, T Leung, W Yeo, W King, W Kwan, M Suen, K Chak, L Lee
SAKK (Swiss Group for Clinical Cancer Research)  
-Inselspital, Bern MF Fey, E Dreher, H Schneider, S Aebi, K Buser, J Ludin, G Beck, H Bürgi, A Haenel, JM Lüthi, R Markwalder, HJ Altermatt, M Nandedkar
-Kantonsspital, St Gallen HJ Senn, B Thürlimann, Ch. Oehlschlegel, G Ries, M Töpfer, U Lorenz, B Späti
-IOSI (Istituto Oncologico della Svizzera Itraliana) Ospedale San Giovanni, Bellinzona F Cavalli, C Sessa, G Martinelli, M Ghielmini, P Luscieti, J Bernier, E Pedrinis, T Rusca; A Goldhirsch
-Centre Hôpitalier Universitaire, Lausanne L Perey, S Leyvraz, P Anani, C Genton, F Gomez, P De Grandi, P Reymond, R Mirimanoff, M Gillet, JF Delaloye
-Hôpital Cantonal, Geneva P Alberto, H Bonnefoi, P Schäfer, F Krauer, M Forni, M Aapro, R Egeli, R Megevand, E Jacot-des-Combes, A Schindler, B Borisch, S Diebold
-Kantonsspital, Zürich Ch. Sauter, U Metzger, V Engeler, U Haller, R Caduff
The Institute of Oncology, Ljubljana, Slovenia J Lindtner, D Eržen, E Majdic, B Stabuc, A Plesnicar, R Golouh, J Lamovec, J Jancar, I Vrhoved, M Kramberger